Nalaganje...

Preparation of sustained release apremilast-loaded PLGA nanoparticles: in vitro characterization and in vivo pharmacokinetic study in rats

BACKGROUND: Apremilast (APM) is a novel, orally administered small molecule drug approved for treatment of psoriasis or psoriatic arthritis. Due to its low solubility and permeability, it is classified as a class IV drug according to BCS classification. Dose titration is recommended during APM treat...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Int J Nanomedicine
Main Authors: Anwer, Md Khalid, Mohammad, Muqtader, Ezzeldin, Essam, Fatima, Farhat, Alalaiwe, Ahmed, Iqbal, Muzaffar
Format: Artigo
Jezik:Inglês
Izdano: Dove Medical Press 2019
Teme:
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC6402442/
https://ncbi.nlm.nih.gov/pubmed/30880967
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/IJN.S195048
Oznake: Označite
Brez oznak, prvi označite!